Agilysys (AGYS) Valuation After Expanded InfoGenesis Rollout Across IHG Hotels & Resorts

Agilysys (AGYS) just secured a broader role with IHG Hotels & Resorts, as its InfoGenesis cloud POS platform has been approved across IHG’s global portfolio, spanning every hotel segment and brand tier.

See our latest analysis for Agilysys.

That deeper IHG rollout comes as Agilysys trades around $126.41, with a 3 month share price return of 14.34% but a slightly negative year to date share price return. This suggests long term momentum is still intact even as near term enthusiasm cools.

If this kind of hospitality tech story has your attention, it is also worth exploring high growth tech and AI stocks that could be setting up for their next growth leg.

With the stock now sitting roughly 12% below analyst targets after a strong multi‑year run, the key question becomes whether Agilysys is still mispriced for its growth runway or if the market already reflects its next chapter.

Most Popular Narrative: 9.7% Undervalued

With Agilysys last closing at $126.41 against a narrative fair value of $140, the storyline leans toward upside potential baked into recurring growth.

The analysts have a consensus price target of $130.4 for Agilysys based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $152.0, and the most bearish reporting a price target of just $120.0.

Read the complete narrative.

Want to see what justifies paying today for tomorrow's profits? The narrative leans on aggressive earnings compounding and richer margins to support that $140 figure. Curious which specific growth and profitability levers drive that valuation story and how long they are expected to last?

Result: Fair Value of $140 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, sustained spending to stay ahead in AI and sales, along with intense hospitality competition, could pressure margins and derail the current growth narrative.

Find out about the key risks to this Agilysys narrative.

Another View on Valuation

While the narrative fair value points to upside, our earnings based lens sends a very different message. At roughly 145 times earnings versus 32 for the wider US software sector and a fair ratio of about 38, Agilysys screens as richly priced, leaving little room for execution missteps.

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own Agilysys Narrative

If you see the numbers differently, or prefer to dig into the data on your own terms, you can build a fresh take in just a few minutes: Do it your way.

A great starting point for your Agilysys research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Before you move on, you can identify your next opportunity by using the Simply Wall Street Screener to uncover stocks with powerful trends you may not want to miss.

• Target high potential under the radar opportunities by scanning these 3571 penny stocks with strong financials that pair relatively stronger financials with speculative upside.
• Focus on structural trends in automation and data by zeroing in on these 30 healthcare AI stocks that are reshaping how care is delivered and paid for.
• Strengthen your income strategy by concentrating on these 15 dividend stocks with yields > 3% that aim to balance yield, stability, and long term compounding.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com